FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025
FTI Consulting's Healthcare & Life Sciences Industry Outlook 2025 reveals renewed optimism in the sector, with 79% of leaders feeling positive about the industry's financial outlook, an 11% increase from last year. The survey indicates strong growth potential, with 66% of leaders expecting higher M&A activity and 40% anticipating improved capital raising capabilities.
Key investment areas include obesity treatments, immuno-oncology, gene editing, and AI-powered drug discovery. The survey identifies major challenges: economic uncertainty (38%), cybersecurity (23%), and political uncertainty (22%). In response to increasing cybersecurity threats, 68% of organizations have implemented crisis communications plans, and 53% have conducted crisis simulations.
Regarding the U.S. political landscape, nearly 60% of respondents believed a second Trump administration would positively impact their business, with expectations of reduced federal regulations and a more favorable deal-making environment.
L'Outlook 2025 per il Settore Sanitario e delle Scienze della Vita di FTI Consulting rivela un rinnovato ottimismo nel settore, con il 79% dei leader che si sente positivo riguardo alle prospettive finanziarie dell'industria, un incremento dell'11% rispetto all'anno scorso. Il sondaggio indica un forte potenziale di crescita, con il 66% dei leader che si aspetta un aumento delle attività di M&A e il 40% che prevede un miglioramento delle capacità di raccolta di capitali.
Le principali aree di investimento includono trattamenti per l'obesità, immuno-oncologia, editing genico e scoperta di farmaci basata sull'IA. Il sondaggio identifica le principali sfide: incertezza economica (38%), cybersecurity (23%) e incertezza politica (22%). In risposta all'aumento delle minacce informatiche, il 68% delle organizzazioni ha implementato piani di comunicazione di crisi e il 53% ha condotto simulazioni di crisi.
Riguardo al panorama politico degli Stati Uniti, quasi il 60% degli intervistati credeva che una seconda amministrazione Trump avrebbe avuto un impatto positivo sul loro business, con aspettative di una riduzione delle normative federali e un ambiente di affari più favorevole.
El Informe de Perspectivas 2025 de la Industria de Salud y Ciencias de la Vida de FTI Consulting revela un renovado optimismo en el sector, con el 79% de los líderes sintiéndose positivos sobre las proyecciones financieras de la industria, un aumento del 11% con respecto al año pasado. La encuesta indica un fuerte potencial de crecimiento, con el 66% de los líderes esperando una mayor actividad de M&A y el 40% anticipando una mejora en las capacidades de recaudación de capital.
Las áreas clave de inversión incluyen tratamientos para la obesidad, inmuno-oncología, edición genética y descubrimiento de fármacos impulsado por IA. La encuesta identifica los principales desafíos: incertidumbre económica (38%), ciberseguridad (23%) e incertidumbre política (22%). En respuesta al aumento de amenazas cibernéticas, el 68% de las organizaciones ha implementado planes de comunicación de crisis y el 53% ha llevado a cabo simulaciones de crisis.
Respecto al panorama político de EE. UU., casi el 60% de los encuestados creía que una segunda administración Trump impactaría positivamente su negocio, con expectativas de una reducción de las regulaciones federales y un entorno de negociación más favorable.
FTI 컨설팅의 2025년 의료 및 생명 과학 산업 전망은 이 부문에 대한 새로운 낙관론을 드러내며, 79%의 리더가 산업의 재무 전망에 대해 긍정적으로 느끼고 있다고 응답했습니다. 이는 작년 대비 11% 증가한 수치입니다. 설문조사는 강력한 성장 잠재력을 나타내며, 66%의 리더가 M&A 활동 증가를 예상하고 40%가 자본 조달 능력 향상을 기대하고 있습니다.
주요 투자 분야로는 비만 치료, 면역 종양학, 유전자 편집, AI 기반 약물 발견이 포함됩니다. 설문조사는 주요 도전 과제를 다음과 같이 식별했습니다: 경제적 불확실성(38%), 사이버 보안(23%), 정치적 불확실성(22%). 증가하는 사이버 보안 위협에 대응하여, 68%의 조직이 위기 커뮤니케이션 계획을 시행했으며 53%는 위기 시뮬레이션을 수행했습니다.
미국의 정치적 환경에 관하여 거의 60%의 응답자가 두 번째 트럼프 행정부가 자신의 비즈니스에 긍정적인 영향을 미칠 것이라고 믿었으며, 연방 규제 완화 및 더 유리한 거래 환경을 기대하고 있었습니다.
Les Perspectives 2025 de l'Industrie de la Santé et des Sciences de la Vie de FTI Consulting révèlent un nouvel optimisme dans le secteur, avec 79% des dirigeants se disant positifs quant aux perspectives financières de l'industrie, soit une augmentation de 11% par rapport à l'année dernière. L'enquête indique un fort potentiel de croissance, avec 66% des dirigeants s'attendant à une activité accrue en matière de fusion-acquisition et 40% anticipant une amélioration des capacités de levée de fonds.
Les principaux domaines d'investissement comprennent les traitements de l'obésité, l'immuno-oncologie, l'édition génétique et la découverte de médicaments alimentée par l'IA. L'enquête identifie des défis majeurs : l'incertitude économique (38%), la cybersécurité (23%) et l'incertitude politique (22%). En réponse aux menaces croissantes en matière de cybersécurité, 68% des organisations ont mis en œuvre des plans de communication de crise, et 53% ont réalisé des simulations de crise.
Concernant le paysage politique américain, près de 60% des répondants estiment qu'une deuxième administration Trump aurait un impact positif sur leur activité, avec des attentes d'une réduction des réglementations fédérales et d'un environnement de négociation plus favorable.
Der Gesundheits- und Lebenswissenschaftsindustrieausblick 2025 von FTI Consulting zeigt einen erneuten Optimismus in der Branche, wobei 79% der Führungskräfte eine positive Einstellung zur finanziellen Zukunft der Industrie haben, was einen Anstieg von 11% im Vergleich zum Vorjahr darstellt. Die Umfrage weist auf ein starkes Wachstumspotenzial hin, da 66% der Führungskräfte eine höhere M&A-Aktivität erwarten und 40% mit verbesserten Möglichkeiten zur Kapitalbeschaffung rechnen.
Wichtige Investitionsbereiche umfassen Behandlungen von Fettleibigkeit, Immunonkologie, Genbearbeitung und KI-gestützte Arzneimittelentdeckung. Die Umfrage identifiziert wesentliche Herausforderungen: wirtschaftliche Unsicherheit (38%), Cybersecurity (23%) und politische Unsicherheit (22%). Als Antwort auf die zunehmenden Bedrohungen durch Cyberangriffe haben 68% der Organisationen Krisenkommunikationspläne implementiert und 53% haben Krisensimulationen durchgeführt.
Zum politischen Umfeld in den USA glaubten fast 60% der Befragten, dass eine zweite Trump-Administration ihre Geschäfte positiv beeinflussen würde, da sie mit einer Reduzierung der föderalen Vorschriften und einem günstigeren Geschäftsumfeld rechnen.
- None.
- None.
Economic Uncertainty, Cybersecurity Incidents and Political Uncertainty Seen as Key Challenges
Industry Increasingly Investing in Cybersecurity Preparedness
WASHINGTON, Dec. 19, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the results of its U.S. Healthcare & Life Sciences Industry Outlook 2025, which found that after years of tempered expectations,
According to the survey,
“After years of speculation and tempered optimism, M&A activity is expected to increase in 2025, as companies predominantly look to acquire viable, late-stage assets in order to grow their pipeline and accomplish their business objectives,” said Robert Stanislaro, a Senior Managing Director and Head of the Healthcare & Life Sciences’ Corporate Reputation offering within the Strategic Communications segment at FTI Consulting. “Particular areas of investment include the rise of obesity treatments, an increased focus in immuno-oncology, gene editing and AI-powered drug discovery. The growing optimism amongst industry leaders and key stakeholders opens up the opportunity for companies to position themselves as innovators in the field and rise above the crowded marketplace.”
Looking at potential risks and challenges, those surveyed cited economic uncertainty (
While the survey was conducted prior to the results of the U.S. presidential election, the findings provide insights into how the industry may be preparing for a second Trump administration. In October 2024, nearly 6 in 10 respondents stated that a potential Trump administration would have a positive impact on their business.
“As the industry prepares for a second Trump administration, leaders should expect to see a focus on reducing federal regulations, promoting market-based solutions and competition through a more favorable deal-making environment, addressing the cost of prescription drugs, and decreasing federal involvement in health coverage,” said Lauren Crawford Shaver, Americas Head of Healthcare & Life Sciences within FTI Consulting’s Strategic Communications segment. “While some changes could be implemented via executive orders, other major reforms would require congressional support and face substantial political hurdles. In light of this, industry leaders need to not only monitor but also grow their political relationships at the local, state and federal level.”
Cybersecurity incidents have become increasingly prevalent across the industry. With that, executives are becoming more familiar with the reputational and operational challenges these situations pose and are preparing accordingly. Sixty-eight percent of respondents said they have a crisis communications plan in place and
The full survey report is available here.
About the Survey
This research was conducted online by FTI Consulting’s Strategic Communications segment between September 24 – October 9, 2024, with 250 decision-makers in corporate communications, investor relations, public affairs, business development and marketing for healthcare and life sciences companies in the United States. Forty-three percent of respondents represent large companies (with more than 250 employees), and roughly one third (
About FTI Consulting
FTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 8,300 employees located in 34 countries and territories, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated
FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100
Investor Contact:
Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com
Media Contact:
Matthew Bashalany
+1.617.897.1545
matthew.bashalany@fticonsulting.com
FAQ
What percentage of healthcare leaders are optimistic about FCN's 2025 industry outlook?
What are the top 3 challenges facing the healthcare industry according to FCN's 2025 outlook?
How many healthcare companies have implemented crisis communication plans according to FCN's survey?
What percentage of healthcare leaders expect increased M&A activity in 2025?
What are the key investment areas identified in FCN's Healthcare Industry Outlook 2025?
How many healthcare leaders expect improved capital raising abilities in 2025?
